Table 3. ADC_EPI, ADC_HASTE, ΔSUV_mean and ΔSUV_max for nodal metastases at baseline and early during treatment.

No. of patient	Lymph node metastases*‡
	ADCEPI MRI1 (×10–5 mm2/s)	ADCEPI MRI2 (×10–5 mm2/s)	ADCHASTE MRI1 (×10–5 mm2/s)	ADCHASTE MRI2 (×10–5 mm2/s)	ΔSUVmean PET1-2 (%)	ΔSUVmax PET1-2 (%)
1	93	101	101	107	39.1	28.7
2	80	121	103	136	NA1	NA1
3	109	124	84	68	NA2	NA2
4	67	93	41	74	–51.1	–62.2
5	89	121	66	89	–39.4	–42.7
6	78	95	67	71	–25.7	–30.4
7	72	125	71	93	–37.9	–38.2
8	108	120	91	110	NA3	NA3

*, the lowest ADC-value of all included lymph nodes in one patient; ^‡, the highest SUV-value of all included lymph nodes in one patient; ¹, PET₁ was performed without a transmission scan; ², PET₁ was reconstructed with an aberrant voxel size; ³, PET₂ was not performed; NA, not applicable.